New Advancements in AI for Clinical Use

Naheed Kurji is the President and CEO of Cyclica, a Toronto-based biotechnology company that leverages artificial intelligence and computational biophysics to reshape the drug discovery process. Cyclica leverages artificial intelligence and computational biophysics to reshape the drug discovery process. Can you discuss in what way AI is used in this process? Technology has played a critical role in drug discovery dating back to the '80s. However, the drug discovery and development process is still very inefficient, time consuming and expensive, costing more than 2 billion dollars over 12 years.